Elypta raises $21 million Elypta, part of the Accelerator at Sahlgrenska Science Park, raises $21 million Series A to develop metabolism-based multi-cancer early detection test.
Daring to share innovations across the Nordics Within health innovations we see many similarities in the Nordics in scaling business to shape a brighter future.
Premium test facilities - Nordic Proof The Accelerator is in a new collaboration aiming to catalyse testbed possibilities for West Swedish startups and scaleups when partnering up with Nordic Proof.
Meet us in Almedalen On Sunday 3 July, we will pack our bags, head east and get ready for the Almedalen event.
Don’t be afraid. Go for it! Anders Hyltander is Associate Professor and Strategist Life Science & AI at Sahlgrenska University Hospital. In October last year, he...
Detectivio work paying off Hot on the heels of being invited to join MobilityXlab, Detectivio – a company in Sahlgrenska Science Park’s Healthtech Accelerator progr...
